Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market cagr 11.6%

Page 1


Viral Vectors, Non-Viral Vectors and

Gene Therapy

Manufacturing Market

Viral Vectors, Non-Viral Vectors and Gene Therapy

Manufacturing Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031

Request Sample Report

Viral Vectors, Non-Viral Vectors and Gene Therapy

Manufacturing Market Size and Growth

The Viral Vectors, Non-Viral Vectors, and Gene Therapy Manufacturing market research reports provide insights into market conditions, trends, and growth opportunities. The market size for viral vectors is estimated at $XX billion, while non-viral vectors and gene therapy manufacturing sectors are valued at $XX billion, respectively. Strong growth is expected in all segments due to increased demand for gene therapy treatments.

Companies Covered

(Covid 19 Impact Covered)

◍ BioReliance

◍ Cobra Biologics

◍ Oxford BioMedica

◍ UniQure

◍ FinVector

◍ MolMed

◍ MassBiologics

◍ Richter-Helm

◍ FUJIFILM Diosynth Biotechnologies

◍ Lonza

◍ Aldevron

◍ Eurogentec

◍ Cell and Gene Therapy Catapult

◍ Biovian

The competitive landscape of Viral Vectors, Non-Viral Vectors, and Gene Therapy Manufacturing Market is dominated by companies like Oxford BioMedica, Lonza, and bluebird bio. These companies utilize viral and nonviral vectors to develop gene therapy products, contributing to the growth of the market.

- Oxford BioMedica: £72.4 million

- Lonza: CHF 1.86 billion

- bluebird bio: $368 million

◍ Thermo Fisher Scientific (Brammer Bio)

◍ VGXI

◍ PlasmidFactory

◍ bluebird bio

Request Sample Report

Market Segmentation

By Application

Cancers

Inherited Disorders

Viral Infections

Others

By Product

◍ AAV

Adenoviral

Lentiviral

Retroviral

Plasmid DNA

Other Vectors

Request Sample Report

Market Growth

Request Sample Report

$ X Billion USD

Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Global Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing market cagr 11.6% by ReportPrime - Issuu